Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. (Q42435834)
Jump to navigation
Jump to search
scientific article published on March 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. |
scientific article published on March 1997 |
Statements
Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers (English)
Joseph IB